Multiple Choice
What is the current recommendation of the U.S.Preventative Services Task Force (USPSTF) regarding the use of hormone replacement therapy?
A) The USPSTF recommends the routine use of combined estrogen and progestin for the prevention of chronic conditions,such as cardiovascular disease,osteoporosis,and dementia,in postmenopausal women.
B) The USPSTF recommends against the routine use of combined estrogen and progestin for the prevention of chronic conditions,such as cardiovascular disease,osteoporosis,and dementia,in postmenopausal women.
C) The USPSTF recommends the routine use of estrogen,but not progestin,for the prevention of chronic conditions,such as cardiovascular disease,osteoporosis,and dementia,in postmenopausal women.
D) The USPSTF recommends the routine use of progestin,but not estrogen,the prevention of chronic conditions,such as cardiovascular disease,osteoporosis,and dementia,in postmenopausal women.
Correct Answer:

Verified
Correct Answer:
Verified
Q1: When a patient has a calcium deficiency,a
Q3: Recombinant human parathyroid hormone (PTH)causes bone density
Q4: Which food is not considered to be
Q5: Which medical conditions are associated with an
Q6: What unique property does calcitonin possess compared
Q7: What is the best description of premenstrual
Q8: Which option is not a secondary goal
Q9: Women between the ages of 15 and
Q10: What is the mechanism of action of
Q11: For which patient population must a clinician